针对D1-CDK4/6复杂蛋白质降解的DNA模板空间控制蛋白解
Rong Zheng1,2, Abhay Prasad1,2, Deeksha Satyabola1,2
1School of Molecular Sciences, Arizona State University, Tempe, Arizona 85281, United States.
Journal of the American Chemical Society
|July 7, 2025
概括
通过DNA模板进行空间控制的PROTACs (DTACs) 能够精确控制药物构成,提高选择性和效力. 这种新的平台为开发有效的近距离治疗方法提供了快速可扩展的方法,包括抗癌药物.
科学领域:
- 生物化学
- 分子生物学
- 药物发现
背景情况:
- 限制基于近距离的药物,如蛋白质分解向化马体 (PROTACs),对于选择性和有效性至关重要.
- 传统的PROTAC合成方法往往复杂且耗时.
研究的目的:
- 引入DNA模板空间控制的PROTAC (DTAC) 作为一种替代合成和空间控制方法.
- 研究精确的抑制剂间距和方向对PROTAC疗效的影响.
主要方法:
- 基于核酸的杆自组件用于DTAC的可编程合成.
- 在癌细胞中评估DTAC对Cyclin D1- CDK4/ 6复合物的选择性和降解能力.
- 在异种移植小鼠模型中评估最佳DTAC结构 (DTAC- V1) 的治疗效果.
主要成果:
- 在DTAC中,Cyclin D1- CDK4/ 6复合物的选择性和降解依赖于距离和方向.
- DTAC-V1实现了该复合体的同步降解,导致G1阶段细胞循环停止并抑制癌细胞增殖.
- 通过抑制瘤生长,DTAC- V1在小鼠模型中显示出显著的治疗效果.
结论:
- DTAC为功能抑制剂的空间控制提供了一个快速,可扩展和模块化的平台.
- 这种方法优化了基于近距离治疗的有效性.
- DTACs是开发新型抗癌药物的有希望的策略.
更多相关视频
相关概念视频
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Separation of Sister Chromatids
3.8K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.8K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
The Proteasome
9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


